Skip to main content
Amikar Sehdev, MD, Oncology, Glendale, AZ

AmikarSehdevMD, MPH, FACP

Oncology Glendale, AZ

Hematologic Oncology

Cancer Specialist

Dr. Sehdev is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sehdev's full profile

Already have an account?

  • Office

    5810 W Beverly Ln
    Glendale, AZ 85306
    Phone+1 623-312-3000
    Fax+1 623-312-3060

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Hematology and Medical Oncology, 2011 - 2014
  • Cook County Health and Hospitals System
    Cook County Health and Hospitals SystemResidency, Internal Medicine, 2007 - 2010
  • Government Medical College Chandigrah
    Government Medical College ChandigrahClass of 2002

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 2019 - 2025
  • IN State Medical License
    IN State Medical License 2014 - 2021
  • CA State Medical License
    CA State Medical License 2018 - 2020
  • IL State Medical License
    IL State Medical License 2007 - 2017
  • UT State Medical License
    UT State Medical License 2010 - 2012
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Phase I Study of EUS-Guided Photodynamic Therapy for Locally Advanced Pancreatic Cancer  
    John M Dewitt, Bert O'Neil, Amikar Sehdev, Safi Shahda, Gastrointestinal Endoscopy
  • Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX  
    Olumide Gbolahan, Amikar Sehdev, Howard H Wu, Safi Shahda, Clinical Cancer Research